Inner Mongolia Furui Medical Science Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000KG1
CNY
55.95
4.55 (8.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 12.56% and Operating profit at 21.74% over the last 5 years

 
2

Positive results in Sep 25

3

With ROE of 8.88%, it has a very expensive valuation with a 11.03 Price to Book Value

4

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 15,142 Million (Large Cap)

stock-summary
P/E

124.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.37

stock-summary
Return on Equity

10.38%

stock-summary
Price to Book

7.95

Revenue and Profits:
Net Sales:
360 Million
(Quarterly Results - Mar 2026)
Net Profit:
52 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.4%
0%
-14.4%
6 Months
-28.13%
0%
-28.13%
1 Year
75.61%
0%
75.61%
2 Years
4.23%
0%
4.23%
3 Years
95.49%
0%
95.49%
4 Years
221.37%
0%
221.37%
5 Years
586.5%
0%
586.5%

Inner Mongolia Furui Medical Science Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
12.56%
EBIT Growth (5y)
21.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.75
Tax Ratio
27.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.67%
ROE (avg)
9.89%

Valuation key factors

Factor
Value
P/E Ratio
124
Industry P/E
Price to Book Value
11.03
EV to EBIT
70.30
EV to EBITDA
51.75
EV to Capital Employed
16.55
EV to Sales
13.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.55%
ROE (Latest)
8.88%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 8.99% vs 3.02% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 24.94% vs -36.24% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "360.10",
          "val2": "330.40",
          "chgp": "8.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "68.90",
          "val2": "93.30",
          "chgp": "-26.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.60",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "52.10",
          "val2": "41.70",
          "chgp": "24.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "191.20%",
          "val2": "204.70%",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.31% vs 17.77% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 31.90% vs 10.62% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,592.80",
          "val2": "1,346.30",
          "chgp": "18.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "504.50",
          "val2": "379.90",
          "chgp": "32.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.60",
          "val2": "3.00",
          "chgp": "20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.10",
          "val2": "-7.70",
          "chgp": "-70.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "258.40",
          "val2": "195.90",
          "chgp": "31.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "250.90%",
          "val2": "211.50%",
          "chgp": "3.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
360.10
330.40
8.99%
Operating Profit (PBDIT) excl Other Income
68.90
93.30
-26.15%
Interest
0.90
0.60
50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
52.10
41.70
24.94%
Operating Profit Margin (Excl OI)
191.20%
204.70%
-1.35%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 8.99% vs 3.02% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 24.94% vs -36.24% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,592.80
1,346.30
18.31%
Operating Profit (PBDIT) excl Other Income
504.50
379.90
32.80%
Interest
3.60
3.00
20.00%
Exceptional Items
-13.10
-7.70
-70.13%
Consolidate Net Profit
258.40
195.90
31.90%
Operating Profit Margin (Excl OI)
250.90%
211.50%
3.94%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 18.31% vs 17.77% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 31.90% vs 10.62% in Dec 2024

stock-summaryCompany CV
About Inner Mongolia Furui Medical Science Co., Ltd. stock-summary
stock-summary
Inner Mongolia Furui Medical Science Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available